Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome

Active, not recruitingOBSERVATIONAL
Enrollment

212

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2029

Study Completion Date

July 31, 2029

Conditions
Postural Orthostatic Tachycardia Syndrome
Interventions
OTHER

History

the physician / PI will conduct a history that may include: demographics Framingham risk factors metabolic diseases inflammatory diseases autoimmune disorders review of medications date of last menstrual period (females) family history of autonomic disorders Onset of postural orthostatic tachycardia syndrome

OTHER

Physical

"the physical exam will include: height weight orthostatic vitals (heart rate and blood pressure), supine and standing for up to 10 minutes.~Beighton Criteria for Join Hypermobility Syndrome Dependent acrocyanosis"

OTHER

blood draw

"blood will be drawn for: antibodies regulating cardiovascular function inflammatory markers~no more than 15 ml (1 TBSP) will be drawn."

BEHAVIORAL

Questionnaires

"The questionnaires will be completed directly online (web-based interface) using a personalized link that will be provided to the subjects after they give their informed consent. These will be created in a REDCap-Survey environment, with the data collected and stored on a password-protected, HIPAA-compliant, secure computer server.~The following questionnaires will be conducted:~RAND-36 Health Thermometer Chalder Fatigue Scale Daily diary of Fatigue Symptoms - Fibromyalgia Pain Detect Questionnaire Orthostatic Grading Scale COMPASS-31"

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT02196376 - Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome | Biotech Hunter | Biotech Hunter